| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.21 | 0.3 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |